AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Understand when to choose target date retirement over index and why the choice matters for long-term planning. This intro explains the core considerations for a simple, informed decision.
25,703 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Traders weigh a potential pivot: if Bitcoin holds steady, the crypto scene may spark a 'solana summer' that could lif...
Fresh data from Stanford and ADP shows AI exposure weighing on entry-level hiring, challenging hopes that automation ...
AMD’s surprise move to buy MEXT promises AI-driven memory optimization that could trim data center costs. Learn what ...
Illinois becomes the first state to tax crypto by transaction, signaling how states may monetize digital assets even ...
Ethereum hovers around $1,585 after a sharp weekly slide, with analyst Tom Lee arguing that quarter-end window dressi...
Broadcom’s custom silicon advantage dominates the AI hardware beat, delivering outsized revenue growth while Marvell ...
Meta Platforms rolls out a new AI compute offering for external customers, aiming to outpace cloud giants. The move t...
U.S. markets wobbled as Opendoor dropped on margin concerns while housing demand hints kept some optimism alive. This...
Cadence Design Systems posted a strong Q1 FY2026, underscoring a rising demand for AI chip design tools. A record bac...
This week brought a notable pullback in AI hardware names, including CoreWeave. Read a clear, practical look at what ...
Lululemon faced a sharp setback as the year unfolded, leaving investors asking if the brand can recover. This guide b...